All in all, as the core signaling pathway downstream of peripheral insulin action or a potent regulator of β cell function, the PI3K/AKT pathway holds a great power in the regulation of T2DM progression, and a notable potential to be a drug target for effectively treating T2DM. The gene discussed is INS; the disease is type 2 diabetes mellitus.